The record
Written from the 1 report below. Nothing here is unsourced.
- US President Donald Trump has announced steep tariffs on imported generic medicines, which will be introduced in phases.
- Tariffs will be zero on all generic medicines entering the US from August 1, 2026 for two years, then rise to 100% for a year, and then increase to 200% starting August 2028.
- The stated aim is to encourage production of generic medicines within the United States.
- The move could significantly affect India, which is the largest exporter of generic medicines to the US.
What to watch next
- How India, as the top generic medicine exporter to the US, responds to the tariff plan
- Whether the tariff schedule remains unchanged through its phase-in from zero to 200% by August 2028
Coverage1
1 report
Indian-language1
All filed from India
Named United States · India · Donald Trump
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.